Furthermore, the combination of β-phenylethyl isothiocyanate and vorinostat (HDAC inhibitor) significantly reduced the cell viability of HL60/LR cells (leukemia cell line) by inhibiting glutathione-associated enzymes that lead to glutathione depletion. This evidence concerns the gene HDAC9 and leukemia.